Analyst Reco. ALK-Abelló A/S

Stocks

Market Closed - Nasdaq Copenhagen Other stock markets 16:20:00 13/07/2026 BST			5-day change	1st Jan Change
240.40 ^DKK	-0.91%		-0.50%	+5.16%

06-15	ALK Receives UK Approval For EURneffy 1 Mg As The First And Only Needle-Free Adrenaline Treatment For Young Children At Risk Of Anaphylaxis	CI
06-15	UK Regulator OKs Lower Dose of ALK-Abelló's Severe Allergic Reaction Treatment	MT

05-28	Berenberg Starts ALK-Abelló at Buy on Growth Potential Amid Food Allergy Market Entry Plans	MT
02-16	DNB Carnegie Upgrades ALK-Abelló to Buy	MT
01-29	Alk gets positive recommendation for Eurneffy 1 mg nasal spray	RE